Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

“Abbott’s representations of its toddler nutrition products are accurate, and our claims are well-supported.” The class action suit wants Abbott to change its marketing practices and return ...

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products ...

Abbott, a health care products conglomerate based in Illinois, is misleading parents and other caregivers about the nutritional value of its sugar-laden toddler milks, according to a lawsuit filed ...

Abbott Laboratories ABT shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value of 4.91X is significantly lower than the industry average ...

Abbott Laboratories (NYSE:ABT – Get Free Report) is expected to be releasing its earnings data before the market opens on ...

Abbott (ABT) ended the recent trading session ... The average PEG ratio for the Medical - Products industry stood at 2.3 at the close of the market yesterday. The Medical - Products industry ...

Jan. 17, 2025 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating whether the board of directors of TKO Group Holdings, Inc. (NYSE ... sell different types of products and services to both ...

The latest trading day saw Abbott (ABT) settling at $113.19, representing a +0.78% change from its previous close.